Prognostic significance of isolated HMB45 or Melan A positive cells in melanoma sentinel lymph nodes

American Journal of Surgical Pathology

Volumn 31, Issue 8, 2007, Pages 1175-1180

  Satzger, Imke ^a   Völker, Bernward ^a   Meier, Andre ^a   Schenck, Florian ^a   Kapp, Alexander ^a   Gutzmer, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Melanoma; Prognosis; Sentinel lymph node; Tumor burden

Indexed keywords

HOMATROPINE METHYL BROMIDE 45; MELAN A; TROPANE DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIGEN PURIFICATION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MALE; MELANOMA; MICROMETASTASIS; OVERALL SURVIVAL; SCHOOL CHILD; SENTINEL LYMPH NODE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 34547631945     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3180341ebc     Document Type: Article

References (21)

1. Al Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004;23:7274-7282.
2. Baisden BL, Askin FB, Lange JR, et al. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol. 2000;24:1140-1146.
3. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-3634.
4. Ben Porat L, Panageas KS, Hanlon C, et al. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma. Cancer. 2006;106:163-171.
5. Carlson GW, Murray DR, Lyles RH, et al. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol. 2003;10:575-581.
6. Cascinelli N, Clemente C, Bifulco C, et al. Do patients with tumor-positive sentinel nodes constitute a homogeneous group? Ann Surg Oncol. 2001;8:35S-37S.
7. Cochran AJ, Balda BR, Starz H, et al. The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer. 2000;89:236-241.
8. Cochran AJ, Wen DR, Huang RR, et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol. 2004;17:747-755.
9. Cserni G. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol. 1999;52:922-924.
10. Dowlatshahi K, Fan M, Snider HC, et al. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. 1997;80:1188-1197.
11. Gershenwald JE, Thompson W, Mansfield PF, et al. Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-983.
12. Gutzmer R, Kaspari M, Brodersen JP, et al. Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies. Histopathology. 2002;41:510-518.
13. Kaufmann R, Tilgen W, Garbe C. Malignant melanoma. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V. Hautarzt. 1998;48(suppl 1):S30-S38.
14. Luzzi KJ, MacDonald IC, Schmidt EE, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol. 1998;153:865-873.
15. Ranieri JM, Wagner JD, Azuaje R, et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol. 2002;9:975-981.
16. Scolyer RA, Li LX, McCarthy SW, et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol. 2004;122:532-539.
17. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628-3636.
18. Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol. 2004;11:162S-168S.
19. Ulmer A, Fischer JR, Schanz S, et al. Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes. Clin Cancer Res. 2005;11:5425-5432.
20. van Diest PJ. Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol. 1999;52:871-873.
21. Yan S, Brennick JB. False-positive rate of the immunoperoxidase stains for MART1/Melan A in lymph nodes. Am J Surg Pathol. 2004;28:596-600.